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Abstract—The process of neurovascular coupling ensures that increases in neuronal activity are fed by increases
in cerebral blood ﬂow. Evidence suggests that neurovascular coupling may be impaired in Multiple Sclerosis (MS)
due to a combination of brain hypoperfusion, altered cerebrovascular reactivity and oxygen metabolism, and
altered levels of vasoactive compounds. Here, we tested the hypothesis that neurovascular coupling is impaired
in MS. We characterized neurovascular coupling as the relationship between changes in neuronal oscillatory
power within the gamma frequency band (30–80 Hz), as measured by magnetoencephalography (MEG), and asso-
ciated hemodynamic changes (blood oxygenation level dependent, BOLD, and cerebral blood ﬂow, CBF) as mea-
sured by functional MRI. We characterized these responses in the visual cortex in 13 MS patients and in 10
matched healthy controls using a reversing checkerboard stimulus at ﬁve visual contrasts. There were no sig-
niﬁcant group diﬀerences in visual acuity, P100 latencies, occipital gray matter (GM) volumes and baseline CBF.
However, in the MS patients we found a signiﬁcant reduction in peak gamma power, BOLD and CBF responses.
There were no signiﬁcant diﬀerences in neurovascular coupling between groups, in the visual cortex. Our
results suggest that neuronal and vascular responses are altered in MS. Gamma power reduction could be an
indicator of GM dysfunction, possibly mediated by GABAergic changes. Altered hemodynamic responses con-
ﬁrm previous reports of a vascular dysfunction in MS. Despite altered neuronal and vascular responses, neu-
rovascular coupling appears to be preserved in MS, at least within the range of damage and disability studied
here.
This article is part of a Special Issue entitled: MRI and Neuroinflammation.  2018 The Authors. Published by Elsevier Ltd on
behalf of IBRO. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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unction.INTRODUCTION
In the healthy brain, neuronal activity and cerebral blood
ﬂow (CBF) have a close spatial and temporal
relationship: increases in neuronal activity are
associated with local increases in CBF via changes in
blood vessel tone, a process known as neurovascular
coupling. Neurovascular coupling is mediated by thehttps://doi.org/10.1016/j.neuroscience.2018.03.018
0306-4522/ 2018 The Authors. Published by Elsevier Ltd on behalf of IBRO.
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Please cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sinteraction of neuronal, glial and vascular cells (Attwell
and Iadecola, 2002; Girouard and Iadecola, 2006;
Attwell et al., 2010; Petzold and Murthy, 2011) and is
thought to be impaired in many neurovascular and neu-
rodegenerative conditions (Iadecola, 2004; Girouard and
Iadecola, 2006; Cantin et al., 2011). As neurovascular
coupling is a key physiological mechanism in the heathy
brain, its alteration in disease is thought to contribute to
tissue dysfunction and damage.
In Multiple Sclerosis, hypoperfusion is seen in both
GM and normal appearing WM (Swank et al., 1982;
Brooks et al., 1984; Lycke et al., 1993; Sun et al., 1998;
Law et al., 2004; Adhya et al., 2006; D’haeseleer et al.,
2013), as well as reports of impaired vascular reactivity
(Marshall et al., 2014, 2016) and reduced oxygen metabo-
lism (Ge et al., 2012). Vasoactive agents such as nitric
oxide and endothelin-1 that have profound, and often con-
trasting, eﬀects on the vasculature are signiﬁcantly raised
within MS lesions (Smith and Lassmann, 2002;
D’haeseleer et al., 2013). Glial cells have a key role in/licenses/by/4.0/).
clerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
2 R. Stickland et al. / Neuroscience xxx (2018) xxx–xxxresponding to damage in the MS brain, as well as playing
a crucial role in neurovascular coupling (Metea and
Newman, 2006). The combination of these factors may
lead to an alteration of the hemodynamic response to
neuronal activity in MS, the hypothesis tested in this
study.
Here, we investigated neurovascular coupling in MS
using two complementary non-invasive imaging
modalities: magnetoencephalography (MEG) and
functional Magnetic Resonance Imaging (fMRI). fMRI
signals are based on the local vascular response, a
process known as functional hyperaemia. MEG directly
measures magnetic ﬁelds generated by the electrical
currents produced by synchronous activity of thousands
of neurons, the local ﬁeld potential (Hansen et al.,
2010). Both MEG and fMRI signals are thought to largely
reﬂect postsynaptic (dendritic) rather than axonal activity
(Logothetis, 2002; Zhu et al., 2009; Hall et al., 2014).
Commonly, when cortical networks are activated there
is an increase in the signal power of faster oscillations,
i.e. in the gamma band (Demanuele et al., 2007; Jia
and Kohn, 2011). Most ﬁndings show a positive correla-
tion between changes in gamma band activity (typically
>30 Hz) and the hemodynamic response (Mukamel
et al., 2005; Niessing et al., 2005; Zumer et al., 2010),
as well as good spatial coherence between these signals
(e.g., Singh et al., 2002; Muthukumaraswamy and Singh,
2008).
By displaying the same reversing checkerboard
stimulus at ﬁve levels of contrast, we probed neuronal
and hemodynamic responses in the visual cortex,
expecting these responses in the early visual areas to
increase monotonically with increasing contrast
(Goodyear and Menon, 1998; Hall et al., 2005; Henrie
and Shapley, 2005; Muthukumaraswamy and Singh,
2009; Perry et al., 2015). We used the positive relation-
ship between gamma power (30–80 Hz) and hemody-
namic signals as our empirical measure of
neurovascular coupling.
MEG studies investigating MS have mostly used
resting-state paradigms, showing clear network
disruption across theta, alpha and beta frequency bands
(e.g., Cover et al., 2006; Schoonheim et al., 2015; Van
der Meer et al., 2013; Tewarie et al., 2013, 2014, 2015).
At the time of this research, no studies have reported
on gamma oscillatory changes in MS. Given possible
GM dysfunction and damage, we predicted a reduction
in gamma power in the MS group. Based on the vascular
impairments reported in MS, we predicted that the MS
group would have a reduced hemodynamic response to
stimulation, and that neurovascular coupling in the visual
cortex would be altered.
We report no signiﬁcant group diﬀerences in visual
acuity scores, P100 latencies, occipital GM volumes and
baseline CBF. However, in the MS patients we found a
signiﬁcant reduction in peak gamma power, the blood
oxygen-level-dependent (BOLD) response and CBF
response to visual stimulation. The patient group
presented with more varied neurovascular coupling
relationships than the controls, but there was noPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Ssigniﬁcant group diﬀerence in neurovascular coupling, in
the early visual cortex.
EXPERIMENTAL PROCEDURES
Subjects
Patients with a diagnosis of MS (Polman et al., 2011)
were recruited at the University Hospital Wales, Cardiﬀ.
Patients were treatment naı¨ve, but eligible to start ﬁrst-
line disease-modifying treatment and had not experi-
enced a relapse in the last 3 months. Age- and gender-
matched healthy controls were recruited. Written consent
was obtained according to the protocol approved by
Research Ethics Committee, Wales, UK.
Testing sessions
All participants had a behavioral session, a MEG and an
MRI scan performed on the same day, except for one
control who returned on a diﬀerent day for the MRI scan.
Behavioral testing. Patients’ disability was assessed
using the Expanded Disability Status Scale (EDSS)
(Kurtzke, 1983). Tests from the MS Functional Composite
(Cutter et al., 1999) were carried out on the patients and
controls: Nine-Hole Peg Test (9-HPT) for upper limb
motor function, the Timed 25 Foot Walk (T25-FW) for
mobility and walking, and the Paced Auditory Serial Addi-
tion Test (PASAT) 2 and 3 s as a measure of sustained
attention. Visual acuity was assessed, in each eye sepa-
rately, with a SLOAN letter chart (Precision Vision) at
100%, 25%, 10%, 2.5%, 1.25% and 0.6% contrast,
expressed as a decimal that represented viewing distance
divided by the letter size (in M-units). All participants
except ﬁve required corrective lenses for daily use and
wore them throughout the testing sessions.
Visual paradigm during scanning. Identical stimulation
parameters were used for fMRI and MEG. The visual
stimulus consisted of a black and white checkerboard,
polarity reversing every 250 ms. Checks were squares,
with a spatial frequency of 1 cycle per degree. The
checkerboard was displayed on a mean luminance
background, with a small red ﬁxation circle in the center.
The rest conditions consisted only of this background
and ﬁxation. For both scanning modalities, the entire
stimulus ﬁeld was 16  16 of visual angle and the
stimulus was projected on screens with a 1024  768
resolution and 60-Hz refresh rate. The checkerboard
was displayed at 5 Michelson contrast levels: 6.25%,
12.5%, 25%, 50% and 100%. Stimuli were displayed in
30-s blocks and each contrast level was presented 4
times. The rest blocks were also 30 s long, but were
presented 8 times. The block order was
pseudorandomized across participants, but for each
participant the same block order was used for both
MEG and fMRI. The task lasted for 14 min and was
repeated twice, once for each eye, with the untested
eye covered with a cotton pad. We tested separate
eyes because a common initial presentation of MS isclerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
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characterized by a reduction in visual acuity and
connectivity in visual pathways (Polman et al., 2011;
Toosy et al., 2014). The experiments were programmed
in MATLAB, using the Psychophysics Toolbox extensions
(Kleiner et al., 2007).MEG data acquisition. A 275-channel CTF axial
gradiometer system was used to obtain whole-head
MEG recordings, sampled at 1200 Hz (0- to 300-Hz
band-pass). An additional 29 reference channels were
recorded for noise cancelation, and 3 of the 275
channels were turned oﬀ due to excessive sensor noise.
Fiduciary coils were placed at ﬁxed distances from three
anatomical landmarks (nasion, left, and right pre-
auricular) and the positions of the coils were monitored
continuously. For co-registration, these landmarks were
later identiﬁed on the subject’s structural MRI and also
veriﬁed with digital photographs. The MEG data were
acquired continuously and epoched oﬄine.MRI data acquisition. MRI data were acquired on a 3T
GE HDx MRI system using an eight-channel receiver
head coil. A 3D T1-weighted structural scan was
obtained for each participant: fast-spoiled gradient
recalled echo (FSPGR): acquisition matrix = 256  256
 172, 1  1  1 mm voxels, TE = 2.9 ms, TR = 7.8 ms.
During the visual task, a pulsed arterial spin labeling
(ASL) scan sequence was acquired with a dual
gradient-echo spiral k-space readout (TR/TE1/TE2 = 22
00/3/29 ms, 64  64  12 slices, voxels 3.4  3.4  7 m
m, 1-mm inter-slice gap, ascending order, 22-cm ﬁeld of
view in-plane, ﬂip angle 90), the ﬁrst echo being used
to estimate CBF changes and the second echo being
used for BOLD time series analysis. The proximal
inversion and control for oﬀ-resonance eﬀects (PICORE)
labeling scheme was used, with a label thickness of 20
cm (TI1 = 700 ms, TI2 = 1600 ms for most proximal
slice) and 10-mm gap between labeling slab and bottom
slice. An adiabatic hyperbolic secant inversion pulse
was used with quantitative imaging of perfusion using a
single subtraction (QUIPSS II), with a 10-cm saturation
band thickness (Wong et al., 1998). 191 tag-control pairs
resulted in 382 volumes being acquired over the 14-min
task. While the participant was at rest, two single-echo
multi inversion time, MTI, (post label delay) pulsed ASL
scans (Chappell et al., 2010) were acquired in order to
estimate baseline perfusion (scan 1, inversion times
(TI): 400, 500, 600, 700 ms, scan 2, TIs: 1000, 1100,
1400, 1700 and 2000 ms). The same PICORE labeling
sequence was used as explained above, with a QUIPSS
II cut of at 700 ms for TIs > 700 ms. A variable repetition
time was used in order to minimize scan time. 16 tag-
control pairs for each TI were acquired.
Before both pulsed ASL scans, a calibration scan was
acquired in order to obtain the equilibrium magnetization
(M0) of cerebrospinal ﬂuid for the purposes of perfusion
quantiﬁcation: a single volume with the same acquisition
parameters but without the ASL preparation and with an
eﬀectively inﬁnite TR (so magnetization fully relaxed).
Additionally, a minimum contrast scan was acquired toPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Scorrect for received image intensity variation with the
same previous parameters, except TE = 11 ms, TR =
2 s, and 8 interleaves.
Data analysisBehavioral data analysis. The 9-HPT, T25-FW,
PASAT-2, and PASAT-3 were all scored with the BRB-
N manual (Brief Repeatable Battery of
Neuropsychological Tests in Multiple Sclerosis).
Responses from 9-HPT and the T25-FW were
measured in seconds to complete, and the PASAT in
number of correct trials. For visual acuity, the MAR
value (MAgniﬁcation Requirement – the inverse of the
visual acuity score) was calculated. Values were then
expressed in log(MAR) units, which indicate ‘‘visual
acuity loss”. A value of 0 indicates no loss so is
equivalent to visual acuity at the reference standard
(20/20), and an increment increase of 0.1 log(MAR)
indicates one line of loss.
MEG data analysis. The analysis of MEG data was
performed in MATLAB using the Fieldtrip toolbox
(Oostenveld et al., 2011). First, data segments including
large muscle artifacts were identiﬁed semi-automatically
(by applying individual z-value thresholds to the z-
transformed sensor time-series, band-pass ﬁltered
between 110–140 Hz) and excluded. Second, eye-
movement artifacts and cardiac signals were projected
out of the data using independent component analysis.
The 30-s stimulus blocks were then epoched into 1-s-
long trials (4 reversals within one trial) and the 30-s rest
blocks were also epoched into 1-s trials.
For source localization, each participant’s anatomical
MRI was divided into an irregular grid by warping the
individual MRI to the MNI template brain and then
applying the inverse transformation matrix to the regular
MNI template grid (5-mm isotropic voxel resolution),
allowing source estimates at brain locations directly
comparable across participants. For each grid location
inside the brain, the forward model (i.e., the lead ﬁeld)
was calculated for a single-dipole orientation by singular
value decomposition, using a single-shell volume
conduction model (Nolte, 2003). Source power at each
location was estimated using an LCMV (linearly con-
strained minimum variance) beamformer, where the
weights were computed using a covariance matrix calcu-
lated after band-pass ﬁltering the data between 30 and
80 Hz, combining trials from all conditions. For each par-
ticipant, the voxel of greatest increase in gamma power
(30–80 Hz) was located within either the Calcarine sulcus
(primary visual cortex) or two adjacent regions (cuneus
and lingual gyrus), found by contrasting the 1-s stimulus
epochs with the 1-s baseline epochs (as a percentage
change from baseline). Anatomical masks were created
using the AAL atlas (Tzourio-Mazoyer et al., 2002). At this
peak location, the source-level time-series were recon-
structed by multiplying the sensor-level data by the beam-
former weights. Trials were represented in the time–
frequency domain by calculating the amplitude envelope
of analytic signal obtained with the Hilbert transform.clerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
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separately for each visual contrast condition, using the
approach described in Fig. 1. This analysis was per-
formed separately for the left and right eye acquisitions.
To assess potential alterations in transmission to the
visual cortex, latencies of visual-evoked ﬁelds (VEFs)
were characterized, for the left and right eyes
separately, and across all ﬁve contrast conditions
together. The trials were ﬁrst re-epoched around the
time of reversal (0 s), with the baseline period deﬁned
as -0.04 to 0 s, and the stimulus period as 0 to 0.21 s.
The data were then low-pass ﬁltered at 15 Hz and
baseline corrected. The VEFs were ﬁrst investigated at
the sensor level (mirroring methods used clinically for
VEPs) by averaging over trials for ﬁve posterior occipital
sensors. The VEFs were subsequently also
characterized in source space (more comparable with
the analysis of the gamma power changes) by
multiplying the pre-processed sensor-level data with the
beamformer weights for the location found to be the
peak gamma response to the checkerboard stimuli. For
both types of analysis, the latency of the peak amplitude
between 0 and 0.21 s was then extracted for each
participant.
MRI data analysisLesion ﬁlling. Lesion ﬁlling was carried out with the
FSL function lesion_ﬁlling, following the protocol of
Battaglini et al., 2012, to improve registration, segmenta-
tion and volumetric measures of brain tissue. In brief, a
lesion mask was manually created by drawing around
any visible lesions on the patient’s T1-weighted image.
At least one lesion was visible for 11 out of the 14
patients. For these 11 patients, the lesion mask, their
T1-weighted image, and a white matter mask (FAST seg-
mentation) was used in order to ‘‘ﬁll” the lesion area in the
T1-weighted image with intensities that are similar to
those in the non-lesioned neighborhood (white matter
only).
Tissue volumes. Brain tissue volume, normalized for
subject head size, was estimated with SIENAX in FSL
(Smith et al., 2001, 2002). For patients with visible
lesions, their T1-weighted images with ﬁlled lesions were
inputted. Brain and skull images were extracted from the
single whole-head input data (Smith, 2002). The brain
image was then aﬃne-registered to MNI152 space
(Jenkinson and Smith, 2001; Jenkinson et al., 2002),
using the skull image to determine the registration scaling,
and to obtain the volumetric scaling factor. Next, tissue-
type segmentation with partial volume estimation was car-
ried out (Zhang et al., 2001) in order to calculate total vol-
ume of brain tissue (and volume of gray and white matter
separately), normalized for head size using the volumetric
scaling factor.
Regional GM tissue volumes from the visual cortex
were calculated for each subject. These visual ROIs
were deﬁned functionally, based on signiﬁcant group
activation to the visual checkerboard stimulus (explained
below). The group visual ROI for the left and right eyePlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sstimulation was transformed from standard space to T1
subject space and masked with the GM partial volume
image to give visual GM ROIs for each subject.
Estimates of volume within these ROIs were then
normalized with the volumetric scaling factor outputted
from the SIENAX analysis.BOLD and CBF response to the visual checkerboard
stimulus. The BOLD signal was isolated by surround
averaging the second echo to remove the tag-control
signal, as described previously in Liu and Wong (2005).
Registration of functional data to individual T1 structural
data (linear, 6 degrees of freedom) and then to MNI stan-
dard space (linear, 12 degrees of freedom) was carried
out using FSL FLIRT (Jenkinson and Smith, 2001,
2012). Motion correction of time series data was per-
formed using MCFLIRT (Jenkinson et al., 2002), with
non-brain removal using BET (Smith et al., 2002b), spatial
smoothing using a Gaussian kernel of FWHM 5 mm, with
a high-pass temporal ﬁlter applied with a cut oﬀ of 90 s.
The time series analyses were carried out using FEAT
Version 6, part of FSL (Jenkinson et al., 2012). Using
FEAT, perfusion time courses were modeled from the ﬁrst
echo data with the inclusion of regressors explicitly
describing the tag-control signal diﬀerences. Five stimu-
lus conditions, and an average across the conditions,
were speciﬁed as six output contrasts relative to the rest
conditions.
A high-level analysis was performed with FEAT using
a mixed eﬀects model (FLAME 1 + 2) to model the eﬀect
of group membership. Z statistic images were
thresholded using clusters determined by Z> 2.3 and a
(corrected) cluster signiﬁcance threshold of p= 0.05
(Worsley, 2001). A group region of interest (ROI) was
generated from the output of this group analyses. The
group ROI consisted of common signiﬁcant voxels (based
on the thresholded z-statistic images, for the contrast
averaged across conditions) among BOLD activity in the
control group, BOLD activity in the patient group, CBF
activity in the control group and CBF activity in the patient
group. After binarizing this group ROI and transforming to
subject space for each participant, a percentage signal
increase in BOLD and percentage increase in CBF were
calculated for each participant within that region. This
higher-level analysis and group ROI creation were done
separately for the left and right eye acquisitions. The ﬁnal
BOLD and CBF values were then averaged across eyes
for each participant.Baseline perfusion. As patients with MS are reported
to be hypoperfused at rest (Swank et al., 1982; Brooks
et al., 1984; Lycke et al., 1993; Sun et al., 1998; Law
et al., 2004; Adhya et al., 2006; D’haeseleer et al.,
2013) a measure of resting CBF in ml/per/100 g per min
was quantiﬁed to establish if there were any diﬀerences
in baseline perfusion. Baseline perfusion was estimated
following a protocol described by Warnert et al. (2014),
using in-house scripts that used AFNI and FSL-BASIL.
In brief, ASL scans were ﬁrst motion corrected using
AFNI. All TIs (from both scans) were merged into one

































Fig. 1. Method used to characterize the peak gamma power response, for each participant. After
performing the Hilbert transform on each trail, and averaging over trials, we obtain power changes
in the time–frequency domain, relative to baseline. Shown on the left is a time–frequency plot for
one participant, at one visual contrast (50%). For each 250-ms epochs (corresponding to one
checkerboard reversal), we average over time. We then extract the peak amplitude change from
baseline (on the right) which is shown in this example to be approximately 15%, at 40 Hz (indicated
by the red arrow). We take an average of the four values (one from each of the four 250-ms
epochs) to give the ﬁnal peak gamma power change from baseline.
R. Stickland et al. / Neuroscience xxx (2018) xxx–xxx 5image per TI, averaged over the 16 volumes. The M0
image was registered to this perfusion series and a mask
of the lateral ventricles was created, and this was used in
the subsequent model to calculate the equilibrium magne-
tization of blood (M0). A two-compartment kinetic model
was ﬁtted to the multi-inversion time data to calculate
baseline perfusion, in native space, in ml/100 g/min along
with mean arrival time (Chappell et al., 2010). Individual
subject GM masks (from partial-volume tissue-
segmentation, see Tissue Volumes) were transformed
to native space in order to estimate the baseline blood
ﬂow over GM. The standard-space ROI used in the
checkerboard analysis was also transformed to native
space, and the baseline perfusion in this region was used
to convert fractional estimates of task-induced change in
blood ﬂow to changes in absolute blood ﬂow units.Characterizing neurovascular coupling. We
characterized neurovascular coupling by ﬁtting a linear
model that reﬂected the relationship between the
electrophysiological response and the hemodynamic
response to the visual checkerboard stimulus. Three
coupling models were ﬁtted for each subject: the
relationship between gamma oscillations and the relative
BOLD signal, the relative CBF signal, and the quantiﬁed
CBF signal. We used BOLD signal changes, dependent
on both metabolism and ﬂow, as this has been the
focus of most previous studies relating MEG and fMRI
signals. We used CBF signal changes as they reﬂect
direct perfusion to the capillary bed, more localized to
the active tissue (Buxton, 2009). We also quantiﬁed this
CBF signal change in ml/100 g/min, due to evidence
showing baseline CBF can aﬀect BOLD and CBF
responses to stimulus (e.g., Cohen et al., 2002), and that
absolute changes in CBF may more closely represent the
neuronal response to a stimulus (Whittaker et al., 2016).
For each subject, there were 10 data points: one point
for each visual contrast and for each eye. We chose not to
average across eyes in order to retain useful variance in
the responses between eyes, therefore helping us toPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study. Neurbetter model the relationship
between MEG and fMRI signals. The
gradient of the line, extracted for
each participant, was taken to be our
coupling measure, indicating the
strength of the relationship between
these signals.
Statistical analysis of group diﬀer-
ences and stimulus responses. Sta-
tistical analysis was carried out using
IBM SPSS Statistics (Version 20)
and R software packages (R Core
Team, 2016). Independent t-tests
assessed diﬀerences between MS
patients and controls on age, behav-
ioral measures, tissue volumes and
baseline signals. Mann–Whitney U-
tests were used to assess diﬀerences
between MS patients and controls on
the visual acuity scores, for each con-
trast level tested. Mixed ANOVAswere used to assess the eﬀect of group membership
and eye on the latency of the peak (of the VEFs), and
the eﬀect of group membership and contrast level on peak
gamma power, BOLD and CBF metrics. For the neu-
rovascular coupling measure, gradients and intercepts
were extracted from the linear model that was ﬁtted sep-
arately for each person, and Mann–Whitney U-tests were
used to test the diﬀerences in medians between MS
patients and controls.
For the Mann–Whitney U-tests, an exact sampling
distribution was used for U (Dineen and Blakesley,
1973). For each comparison, the shape of the distribution
was similar between groups, as assessed by visual
inspection, so medians were compared. GG in the results
refers to the Greenhouse–Geisser correction used when
the assumption of homogeneity of variances is violated.
In these statistical analyses, all hypothesis testing was
two-tailed. The family-wise error rate was controlled with
the Holm–Bonferroni correction, a popular variant of the
Bonferroni correction that is less conservative (Holm,
1979).RESULTS
Demographics and clinical proﬁle
The demographic and clinical characteristics of the 14
patients and 10 healthy controls are reported in Table 1.
Patients were signiﬁcantly slower than controls when
completing the 9-HPT task and showed a trend toward
being signiﬁcantly slower in the T25-FW task.Visual acuity and VEFs
One patient was not included in the right eye group
analysis due to blindness of the right eye. The log(MAR)
values were extremely non-normal in their distribution
across eyes and groups, and diﬀerent cells of the
design (group vs. eye vs. contrast level) had diﬀerent
variances. Therefore, as the group diﬀerence was theoscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
Table 1. Demographic and clinical characteristics for patients (n= 14) and controls (n= 10). Values are reported as Mean ± SEM. The 9-HPT is a
mean of two trails for each hand. The T25-FW is a mean of two trials. One patient did not complete the T25-FW testing. The normalized brain volume is
based on the patient’s lesion-ﬁlled T1 weighted images. Signiﬁcance is tested using two-tailed unpaired t-tests, except for diﬀerences in sex, which was
tested with Fisher’s Exact Test
Patients Controls P-value
Age 43.46 ± 3.50 42.40 ± 3.73 0.69
Sex (M/F) 5/9 1/9 0.34
Disease duration (Years) 7.31 ± 2.06 – –
EDSS (Median, Range) 3.0, 0–4.5 – –
History of optic neuritis 6/14 – –
9-HPT (s) 25.65 ± 0.82 22.41 ± 0.95 0.02
T25-FW (s) 13.08 ± 1.58 9.63 ± 0.19 0.05
PASAT-3s (No. correct responses) 46.54 ± 2.57 48.10 ± 3.37 0.71
PASAT-2s (No. correct responses) 31.92 ± 1.86 36.20 ± 2.95 0.21
Normalized Brain Volume (mm3) 1,492,761.57 ± 26644.57 1,523,284.20 ± 25006.90 0.43
6 R. Stickland et al. / Neuroscience xxx (2018) xxx–xxxfocus, separate Mann–Whitney U tests were used to test
the group diﬀerence in the visual acuity at each contrast
level, and the p values were corrected for multiple
comparisons with the Holm–Bonferroni correction.
Group diﬀerences were assessed at each contrast
(100%, 25%, 10%, 5%, 2.5%, 1.25%, 0.6%) and for
each eye (left, right). There were no signiﬁcant group
diﬀerences between MS patients and controls in visual
acuity scores (Table 2).
We investigated the eﬀect of group (controls, patient)
and eye (left, right) on the latency of the peak amplitudes
of the VEFs, for the sensor and source space analyses.
The data were normally distributed, with no outliers.
Results reported here are Mean ± Standard Error of the
Mean(SEM), expressed in milliseconds. For latencies
calculated in sensor space, MS patients (146 ± 9) and
controls (147 ± 10) did not have signiﬁcantly diﬀerent
latencies (F(1,21) = 0.001, p= 0.98), and the left eye
(156 ± 9) and the right eye (137 ± 8) also did not diﬀer
(F(1,21) = 3.04, p= 0.10), for both groups. The results
were similar for latencies calculated in source space:
there was no main eﬀect of group (MS patients: 137 ±
5, controls: 142 ± 6, F(1,21) = 0.38, p= 0.55) and no
main eﬀect of eye (left: 145 ± 6, right: 134 ± 6, F(1,21)
= 1.83, p= 0.19). There was no signiﬁcant interaction
between group and eye for the latencies calculated in
sensor space, (F(1,21) = 0.001, p= 0.98), or source
space (F(1,21) = 0.16, p= 0.70).MEG and fMRI responses to reversing checkerboard
stimuli
There were no signiﬁcant diﬀerences in GM volume,
baseline CBF or baseline gamma power between MS
patients and controls, across the whole brain and within
the regions of interest used to characterize the visual
response to the checkerboard stimulus (Table 3).Spatial comparison of MEG and fMRI results
One control’s fMRI data were not useable due a corrupted
image ﬁle. Fig. 2 displays the location of the ROI used in
the BOLD and CBF analyses, for all participants, overlaid
onto the primary visual cortex. Included in Fig. 2 are the
locations of the peak gamma responses for each patientPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sand control, where the time–frequency analysis was
performed. Fig. 3 shows the whole-brain MEG source
localization plots for each group. Fig. 4 shows the
whole-brain CBF activity for each group, and Fig. 5 the
whole-brain BOLD activity.Eﬀect of group and stimulus contrast on BOLD, CBF
and gamma power change
Given the absence of signiﬁcant diﬀerences in the visual
acuity scores and latency of the peak amplitudes
between groups, the eﬀect of group and stimulus
contrast was statistically tested on data averaged
across the two eyes. Fig. 6 displays the eﬀect of group
and stimulus contrast on BOLD, CBF and peak gamma
power signal changes.
BOLD, CBF quantiﬁed and CBF percent signals
increased signiﬁcantly as stimulus contrast increased:
F (1.75,33.17) = 46.59, p < 0.001 GG; F (4,76) = 35.41,
p < 0.001; F (4,76) = 35.63, p < 0.001, respectively.
MS patients had signiﬁcantly lower signal responses,
compare with controls, for BOLD and CBF quantiﬁed
signals, but this was not signiﬁcant for CBF percent:
F (1,19) = 7.97, p = 0.01; F (1,19) = 6.62, p = 0.02;
F (1,19) = 2.76, p = 0.11, respectively. All pairwise
comparisons between contrast levels were signiﬁcant.
There was no signiﬁcant interaction between the eﬀect
of contrast and group on BOLD changes (F (1.75,
33.17) = 0.86, p = 0.42, GG) CBF quantiﬁed changes
(F (4, 76) = 1.25, p = 0.30), or CBF percent changes
(F (4, 76) = 0.70, p = 0.59).
For the MEG results, there was a signiﬁcant
interaction between the eﬀect of contrast and group on
the peak gamma power changes (F (1.50,31.54) =
7.87, p = 0.01, GG). Therefore, simple main eﬀects
were investigated. There was no signiﬁcant group
diﬀerence at the 6.25% or 12.5% contrast levels
(F (1,21) = 1.13, p = 0.30; F (1,21) = 1.99, p = 0.17,
respectively), but MS patients showed signiﬁcantly lower
peak gamma power changes at 25%, 50%, and 100%
(F (1,21) = 6.28, p = 0.02; F (1,21) = 12.13, p < 0.01;
F (1,21) = 10.71, p < 0.01, respectively). Peak gamma
power signals increased signiﬁcantly as stimulus
contrast increased, for both the control group
(F (1.59,14.29) = 46.03, p < 0.001, GG) and theclerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
Table 2.Median log(MAR) visual acuity scores, compared between MS patients (n= 12) and controls (n= 10), for each contrast level and eye. Higher
median scores indicate greater visual acuity loss. Mann–Whitney U-tests were performed for each group comparison, and the test statistic and
corresponding p-value is reported here. Using the Holm–Bonferroni correction, the last row shows the threshold at which that p-value is signiﬁcant.
There were no signiﬁcant group diﬀerences between median visual acuity scores for any comparison
Eye Visual Contrast (%) Median Mann–Whitney U P value Signiﬁcant if less than
Controls Patients
Left 100 0.10 0.00 52.5 0.63 0.016
25 0.10 0.10 62 0.92 0.05
10 0.20 0.20 69 0.58 0.01
5 0.40 0.49 72.5 0.38 0.006
2.50 0.85 1.00 80 0.20 0.004
1.25 1.65 2.00 73 0.42 0.006
0.60 2.00 2.00 69 0.58 0.01
Right 100 0.00 0.05 79.5 0.20 0.004
25 0.10 0.10 79 0.23 0.005
10 0.20 0.25 71 0.50 0.007
5 0.40 0.49 75 0.35 0.005
2.50 0.80 1.30 82.5 0.14 0.004
1.25 2.00 2.00 71 0.47 0.007
0.60 2.00 2.00 66 0.72 0.025
Table 3. Tissue volumes, and baseline signals compared between groups. GM tissue volumes and baseline cerebral blood ﬂow (bCBF) are compared
for the total GM, as well as for GM within the left ROI (L) and the right (R) which was used to extract the BOLD and CBF responses to the visual
checkerboard stimulus. Baseline gamma power is a mean of the power at each frequency between 30 and 80 Hz, averaged over the 30-s rest block, but
extracted from the same location as the peak gamma response to the checkerboard stimuli. The p-values for GM Volume (3 comparisons), for bCBF (3
comparisons) and bGamma Power (2 comparisons) were corrected separately and compared against the Holm–Bonferroni corrected thresholds: a is
signiﬁcant at p< 0.017, b at p< 0.05, c at p< 0.025
Group N Mean Std. Dev P value
GM Volume (Total) Controls 10 788328.70 55506.80 0.29a
(mm3) Patients 14 755677.88 66346.84
GM Volume (L) Controls 10 5514.29 673.20 1.00c
(mm3) Patients 14 5515.19 768.02
GM Volume (R) Controls 10 4154.44 530.05 0.90b
(mm3) Patients 14 4184.46 585.56
bCBF GM (Total) Controls 10 36.91 10.17 0.90c
(ml/100 g/min) Patients 13 37.34 6.32
bCBF GM (L) Controls 9 57.73 21.18 0.45a
(ml/100 g/min) Patients 13 51.96 15.16
bCBF GM (R) Controls 9 57.30 21.00 0.48b
(ml/100 g/min) Patients 13 51.70 16.81
bGamma Power (L) Controls 10 6.10 0.83 0.10b
(*1014 Tesla) Patients 13 7.07 1.63
bGamma Power (R) Controls 10 6.80 1.19 0.94c
(*1014 Tesla) Patients 13 6.80 1.29
R. Stickland et al. / Neuroscience xxx (2018) xxx–xxx 7patient group (F (1.12, 15.99) = 22.46, p < 0.001, GG).
All pairwise comparisons between contrast levels were
signiﬁcant, except between 6.25% and 12.5%, and
12.5% and 25% in the patient group.Neurovascular coupling in MS patients and controls
The relationship between peak gamma power and BOLD
and CBF signals was compared between groups. Fig. 7
visually displays these coupling relationships, and
Table 4 shows the statistical testing between groups.
Fig. 7A displays the coupling relationships using the
median values across each group. At this groupPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Saveraged level, there is a good ﬁt between the MEG
and fMRI signals. The MS patients appear to have
higher gradients on average (i.e., for the same peak
gamma power change, higher BOLD and CBF change),
as well as lower intercepts on average. Fig. 7B shows
what the coupling relationship looks like for every
participant separately, showing that the patient group
displays more variability in the coupling between peak
gamma power and BOLD change compared to the
controls. CBF coupling results for each participant (not
shown) showed similar trends.
To statistically test these coupling diﬀerences, the
median gradients and intercepts were extracted for eachclerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
Fig. 2. The location of the ROI used to extract the BOLD and CBF responses (yellow) for every
participant, overlaid on the primary visual cortex (red). The top plot shows the left eye analysis and
the bottom plot shows the right eye analysis. The dots indicate the location of the peak voxel (peak
of the gamma response, percentage change from baseline) for each individual participant (blue =
controls, green = MS patients), which was used for the time–frequency analysis of the MEG data.
This is shown for n= 10 controls n= 13 MS patients.
8 R. Stickland et al. / Neuroscience xxx (2018) xxx–xxxperson and compared between groups. In general, higher
gradients and lower intercepts are seen in the patient
group, but no signiﬁcant diﬀerences are found between
groups (Table 4).DISCUSSION
We investigated the neuronal and hemodynamic
responses to a reversing checkerboard visual stimulus
in relapsing–remitting MS, observing smaller peak
gamma power changes and BOLD and CBF responses.Please cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study. NeuroWhile the range of
electrophysiological and
hemodynamic responses were
altered in MS, we found no
signiﬁcant group diﬀerence in the
coupling relationship between these
responses, indicating that
neurovascular coupling may remain
intact in MS. While the lack of
signiﬁcant diﬀerences between
groups may be due to the limited
statistical power of this study, due to
relatively small samples sizes, it may
also reﬂect the complexity and
heterogeneity of MS as a disease,
and neurovascular coupling as a
biological process.Source localization of gamma
oscillations, BOLD and CBF
The group ROI used to extract the
BOLD and CBF signals for all
participants was located clearly in
the primary visual cortex (Fig. 2). For
characterizing the gamma response,
we searched for the peak gamma
power change within the calcarine
sulcus and two adjacent regions: the
cuneus and lingual gyrus. This was
because previous studies suggest
visual gamma, in response to this
type of stimulus, to be located in the
primary visual cortex. This method
also ensured that the area was
comparable to the fMRI source while
allowing for some error in MEG
signal localization. Although we took
a ROI approach to characterizing the
peak gamma, CBF and BOLD
responses, we also visualized these
responses across the whole brain. At
the whole-brain group-averaged
level, we saw a reduction in gamma
power responses in visual areas for
the MS patients (Fig. 3). A reduction
was also seen in sub-cortical and
temporal regions; this possibly
indicates activity diﬀerences more
extensively along visual processing
pathways, yet this was not furtherexplored. For the CBF and BOLD group-average plots,
a similar pattern of activity in the early visual cortex was
seen for both groups (Figs. 4 and 5). There were voxels
within the intra/supra-calcarine cortex and cuneus (for
CBF) and the lingual gyrus, intracalcarine cortex, and
cuneus (for BOLD) showing signiﬁcantly greater activity
in the MS group compared to the controls. A possible
explanation of this result is compensatory functional
reorganization of the cortex in MS patients (Werring
et al., 2000; Tomassini et al., 2012).science (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
Controls Source Power Patients Source Power     Patients - Controls 
0 30-30




Fig. 3. Beamformer contrast images (band-pass ﬁltered 30–80 Hz) measured as percentage change between stimulus and baseline, projected
onto a template brain surface. This is shown for controls (left column) and MS patients (middle column). The right column illustrates the t-statistic
values for the diﬀerence between patients and controls (negative values indicating lower amplitude for patients than controls). Simply for illustration
purposes, t-values are plotted here at the uncorrected level. The data were averaged over both eyes. Only right medial and lateral views are shown;
the same trends were seen for left.
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responses in MS
Here we used the oscillatory activity in the gamma band
(30–80 Hz) to characterize the neuronal response.
Broadly, the gamma rhythm is theorized to reﬂect the
balance between excitatory and inhibitory signaling;
networks of fast-spiking, parvalbumin-expressing,
GABAergic interneurons act on pyramidal cells to bring
about synchronous inhibitory post synaptic potentials
(Bartos et al., 2007; Cardin et al., 2009; Buzsa´ki and
Wang, 2012). A large body of research shows an increase
in gamma power when functional networks are engaged,
widely across the brain and for many diﬀerent processes
(e.g., Jensen et al., 2007; Nyhus and Curran, 2010;
reviewed by Jia and Kohn, 2011). The functional role of
gamma oscillations is not fully known, but it is thought to
be in attention, perception and mediation of information
transfer across diﬀerent cortical areas (Fries, 2009).
Disruptions in gamma oscillations have been reported
in many brain disorders (Uhlhaas and Singer, 2006). In
MS, task-induced changes have remained largely unex-
plored until recently (e.g., Barratt et al., 2017; Arpin
et al., 2017). Barratt et al. (2017) reported signiﬁcantly
reduced visual gamma amplitudes in a similar MS popula-
tion, the only other study, to our knowledge, that hasPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sinvestigated task-induced gamma oscillatory changes in
MS. There is evidence that parvalbumin-expressing
GABAergic interneurons, thought to contribute to gamma
oscillations, are reduced in normal appearing GM of the
motor cortex in MS (Clements et al., 2008), and that sec-
ondary progressive MS patients have signiﬁcantly lower
GABA levels in the hippocampus and sensorimotor cortex
(Cawley et al., 2015). GABA concentration has also been
related to visual gamma oscillations and BOLD signals in
healthy subjects in the visual cortex (Muthukumaraswamy
et al., 2009; Magazzini et al., 2016). Therefore, a possible
interpretation of our results is that these gamma power
reductions in the visual cortex of MS patients could be
an indicator of early GM dysfunction, mediated by
GABAergic changes. However, we did not see a signiﬁ-
cant reduction in GM visual cortices or in whole-brain vol-
umes in the MS group when compared to the healthy
control group. Although, again, this negative ﬁnding may
result from a small sample size, a contributing factor
may be ongoing inﬂammation, as participants were treat-
ment naı¨ve. The contribution of inﬂammation to an
increase in brain volume (and thus to an apparent normal-
ization despite MS pathology) has been indirectly demon-
strated by showing that the onset of disease modifying























Fig. 4. Signiﬁcant CBF voxels at the group level in response to the visual checkerboard stimulus, compared between MS patients and controls.
These data are an average of both eyes. The signiﬁcant activity shown is the average activity across all visual stimulus conditions. Voxels were
thresholded using clusters determined by Z> 2.3 and a (corrected) cluster signiﬁcance threshold of p= 0.05 (Worsley, 2001). The bottom plot
shows voxels that showed signiﬁcantly greater activity in the patient group, compared with controls. This activity was localized to the intracalcarine
and supracalcarine cortex, as well as the cuneus (using Harvard-Oxford Cortical Structural Atlas). There were no voxels showing signiﬁcantly
greater activity for the control group compared to the MS patients. The right side of the image corresponds to the left side of the brain.
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(Gasperini et al., 2002; Zivadinov et al., 2008; Vidal-
Jordana et al., 2016).
Although they presented with preserved visual acuity
and latency of visual-evoked ﬁelds, the MS patients
showed signiﬁcant hemodynamic alterations, in the form
of reduced BOLD and CBF responses to the visual
checkerboard, in the primary visual cortex. In the
context of largely preserved neurovascular coupling,
the reduced hemodynamic response is consistent
with the reduced electrophysiological response.
Changes in the BOLD response to visuomotor tasks
have been previously demonstrated, showing thatPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sinﬂammation and white matter structural damage play a
role in altering hemodynamic responses in MS
(Tomassini et al., 2016; Hubbard et al., 2016). Our alter-
ations in BOLD and CBF responses support these ﬁnd-
ings, as well as altered responses to visual stimuli at
diﬀerent contrasts (Faro et al., 2002). Uzuner and
Uzuner (2016), also using a 2-Hz reversing checkerboard
stimulus, found blood ﬂow velocities in the posterior cere-
bral arteries to be higher in a large MS patient group in the
state of relapse. Though a diﬀerent measure, this is in
contrast to the reduced blood ﬂow responses we reported
in this MS group, but highlights the potential impact of
testing MS participants at diﬀerent stages of the disease.clerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018





















Fig. 5. Signiﬁcant BOLD voxels at the group level in the visual checkerboard stimulus, compared between MS patients and controls. These data are
an average of both eyes. The signiﬁcant activity shown is the average activity across all visual stimulus conditions. Voxels were thresholded using
clusters determined by Z> 2.3 and a (corrected) cluster signiﬁcance threshold of p= 0.05 (Worsley, 2001). The bottom plot shows voxels that
showed signiﬁcantly greater activity in the patient group, compared with controls. This activity was localized to the lingual gyrus, intracalcarine
cortex, pre-cuneus and cuneus (using Harvard-Oxford Cortical Structural Atlas). There were no voxels showing signiﬁcantly greater activity for the
control group compared to the MS patients. The right side of the image corresponds to the left side of the brain.
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MS
The relationship between the peak gamma power change
and the BOLD/CBF response (using the variance given
by the visual contrast manipulation) was our empirical
measure of neurovascular coupling. While this is
intuitive, assuming that the blood ﬂow response only
reﬂects a coupling with gamma oscillatory activity is
simplistic. The amplitude of gamma oscillations can be
modulated by the phase of slower oscillations, termed
cross-frequency phase-amplitude coupling (Buzsa´ki and
Wang, 2012), and an increase in gamma power is oftenPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Saccompanied by a decrease in power of lower frequen-
cies. BOLD and gamma oscillations are also known to
be decoupled in some circumstances. For example, in
the visual cortex, gamma amplitudes are altered with
changes in the spatial frequency and color of the stimuli,
but BOLD signals are not (Muthukumaraswamy and
Singh, 2008, 2009; Swettenham et al., 2013). Despite
these limitations, and although the temporal relationship
of MEG and fMRI signals is complex (Hall et al., 2014),
they are generally thought to originate from the same
electrophysiological source and have reasonable spatial
overlap. Gamma oscillations have high test–retest reliabil-
ity, with stable features within the same participants for atclerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
Fig. 6. The eﬀect of group and visual contrast on peak gamma power, BOLD signal, CBF signal (percentage change from baseline) and CBF signal
(ml/100 g/min change from baseline). The graph displays Mean ± SEM. For BOLD, CBF and CBF quantiﬁed the eﬀect of group was not
signiﬁcantly diﬀerent across contrast level, so the p values refer to the main eﬀect. For Gamma, there was an interaction between group and
contrast level so the p values refer to the simple main eﬀects. *p< 0.05, **p < 0.001. All pairwise comparisons between contrast levels were
signiﬁcant at an alpha level of 0.05, with Holm–Bonferroni correction.
12 R. Stickland et al. / Neuroscience xxx (2018) xxx–xxxleast 4 weeks (Muthukumaraswamy et al., 2010; Tan
et al., 2016), which is important considering the practical
limitation of doing the MEG and fMRI scanning sessions
separately.
In this study, we could not demonstrate signiﬁcant
diﬀerences in neurovascular coupling between the MS
patients and controls. While this may be related to the
power of the study, it may also reﬂect the complexity ofPlease cite this article in press as: Stickland R et al. Neurovascular Coupling During Visual Stimulation in Multiple Sthe biology underlying the relationship between neuronal
activity and the hemodynamic response, which in MS is
aﬀected by the inﬂammatory milieu. Indeed, the
response of blood vessels to neuronal activity is not
only mediated by reactivity of the smooth muscle cells,
but also by neuronal and glial signaling, involving many
chemical mediators. Increased levels of both
vasodilators (e.g., nitric oxide, Smith and Lassmann,clerosis: A MEG-fMRI Study. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2018.03.018
Fig. 7. (A) shows the relationship between peak gamma power change and BOLD, CBF and CBF changes (quantiﬁed) in response to the visual
checkerboard stimulus. Group median values are plotted. Each point represents a diﬀerent contrast level for each eye. The reduced range of
electrophysiological and the hemodynamic responses are evident in the patient group. (B) The relationship between peak gamma power change
and BOLD change shown for each control (n= 9) and each patient (n= 12) separately. The diﬀerent colors represent the diﬀerent participants and
the black lines the linear model ﬁt.
Table 4. Median gradients and intercepts compared between MS patients and controls, using peak gamma power to predict BOLD, CBF and CBF
quantiﬁed (CBFq). Mann–Whitney U-tests were performed for each group comparison, and the test statistic and corresponding p-value is reported
here. The p values are compared against Holm–Bonferroni corrected alpha levels, corrected for two dependent tests (gradient and intercepts)
Outcome measure Median Mann–Whitney U P value Signiﬁcant if less than:
Controls Patients
Gradient BOLD 0.03 0.04 66 0.42 0.050
CBF 1.03 1.30 65 0.46 0.050
CBF(q) 0.67 0.58 58 0.81 0.050
Intercept BOLD 0.31 0.04 24 0.03 0.025
CBF 5.08 1.97 38 0.28 0.025
CBF(q) 3.91 1.16 35 0.19 0.025
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14 R. Stickland et al. / Neuroscience xxx (2018) xxx–xxx2002) and vasoconstrictors (e.g., endothelin-1,
D’haeseleer et al., 2013) have been reported in MS, due
to the proliferation of glial cells to damaged areas, which
could interfere with neurovascular coupling pathways in
contrasting ways. In line with the hypothesis that inﬂam-
mation aﬀects neurovascular coupling, there is the evi-
dence that the MS group appeared to display more
variance in their coupling relationships, suggesting a
greater inter-individual variability.
While not signiﬁcantly diﬀerent from healthy
volunteers, the analysis of the neurovascular coupling
showed a trend for the MS group to have lower
intercepts and higher gradients, when predicting the
BOLD and CBF changes from the peak gamma power
changes. An increased blood ﬂow response, for same
gamma power change, may seem counterintuitive
considering the reports of blood vessels being less
reactive in MS (Marshall et al., 2014; Marshall et al.,
2016). However, an increased blood ﬂow response could
reﬂect the need to deliver more oxygen or nutrients to tis-
sue, if there is ineﬃciency in their use to support a given
level of electrophysiological activity.CONCLUSIONS
We found evidence for reduced neuronal and
hemodynamic responses in the early visual cortex in MS
in response to visual stimulation, in the absence of
substantial functional impairments to visual acuity or
delayed visual-evoked ﬁelds. We could not demonstrate
a signiﬁcant alteration in neurovascular coupling in MS
patients. Further research into neurovascular and
metabolic function across the whole brain, and at
diﬀerent disease stages, will help uncover the
importance of these processes in MS.ACKNOWLEDGMENTS
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